Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MCHR1 inhibitors(Melanin-concentrating hormone receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prader-Willi Syndrome | Phase 2 | FR | 22 Sep 2022 | |
Prader-Willi Syndrome | Phase 2 | US | 22 Sep 2022 | |
Prader-Willi Syndrome | Phase 2 | CZ | 22 Sep 2022 | |
Prader-Willi Syndrome | Phase 2 | ES | 22 Sep 2022 | |
Prader-Willi Syndrome | Phase 2 | IT | 22 Sep 2022 |